Bencure > Diabetology > Benglim Trio

Benglim Trio



Glimepiride ½ mg + Metformin 500 mg + Pioglitazone 15 mg Tablets

Paradigm shift in target management

  • Rapid intensification with Trio achieves more aggressive goals
  • Decreases hepatic glucose uptake, improves insulin sensitization and secretion
  • Ensures cardiovascular benefits like reduction in BP & improved diabetic dyslipidaemia
  • Preserves and improves β-cells function
  • Lowers HbA1C to a greater degree
  • 50% reduction in the progression to permanent insulin use